Do you consider local therapy in a patient with de novo metastatic triple negative breast cancer who has a complete response to first line chemotherapy?  

I guess the question refers to a complete response in all detectable sites of metastasis and the primary. SHould that be the case, I would consider local therapy of the breast and the metastases if they were few (<3). Otherwise, I do not think the existing data are strong enough to do it.